Debora A. Jorn
2014
In 2014, Debora A. Jorn earned a total compensation of $2.3M as Executive Vice President, Company Group Chairman at Valeant Pharmaceuticals International, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,827 |
|---|---|
| Salary | $396,577 |
| Stock Awards | $1,538,192 |
| Other | $11,505 |
| Total | $2,267,101 |
Jorn received $1.5M in stock awards, accounting for 68% of the total pay in 2014.
Jorn also received $320.8K in non-equity incentive plan, $396.6K in salary and $11.5K in other compensation.
Rankings
In 2014, Debora A. Jorn's compensation ranked 4,012th out of 13,032 executives tracked by ExecPay. In other words, Jorn earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,012 out of 13,032 | 69th |
Division Manufacturing | 1,418 out of 4,967 | 72nd |
Major group Chemicals And Allied Products | 460 out of 1,690 | 73rd |
Industry group Drugs | 355 out of 1,369 | 74th |
Industry Pharmaceutical Preparations | 284 out of 1,042 | 73rd |
Source: SEC filing on April 29, 2016.
Jorn's colleagues
We found six more compensation records of executives who worked with Debora A. Jorn at Valeant Pharmaceuticals International in 2014.
2014
Ari Kellen
Valeant Pharmaceuticals International
Group Chairman
2014
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2014
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2014
Pavel Mirovsky
Valeant Pharmaceuticals International
President and General Manager, Europe
2014
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2014
Brian Stolz
Valeant Pharmaceuticals International